tirzepatide kidney stones Is Zepbound Hard on the Kidneys? Risks and Protection Kidney Stones & Ozempic: Clinical

GLP-1RAs are a relatively new class of injectables that are effective at reducing HbA 1c , have a low risk of hypoglycaemia when given as monotherapy or in the absence of sulphonylureas (SU) or insulin, and have the potential for weight losskey considerations when treating a typical obese patient with T2DM [4]

When cravings are reduced, it becomes easier for individuals to stick to a balanced diet that supports weight loss

Supported by: So Paulo State Research Foundation - FAPESP: 2019/13210-0 Disclosure: D.E

Agenda Additional speakers to be announced

Oral semaglutide (Rybelsus) marks an important milestone, and were seeing intense activity around alternative delivery platforms, such as implantables, depots, and even transdermal systems, that could simplify treatment and improve adherence